logo-bullish-stock-alerts
  • About
    • FAQ
    • Client Reviews
    • Pricing
  • Contact
  • Investment portfolios
  • Blog
    • Investing Strategies
    • Market News
    • Cryptocurrency News
    • Investing Tools and Regulations
  • Login
    • My Account
    • Invoices
    • Edit Profile
Join our free newsletter!
Citius Pharmaceuticals Inc. ($CTXR): Don’t Miss This Explosive Opportunity Before FDA Approval!

Citius Pharmaceuticals Inc. ($CTXR): Don’t Miss This Explosive Opportunity Before FDA Approval!

by Aaron E. | Jul 16, 2024 | Market News

Introduction Citius Pharmaceuticals Inc. (NASDAQ: CTXR) is a biopharmaceutical company dedicated to developing and commercializing critical care products, focusing on oncology, anti-infectives, and stem cell therapy. With a significant catalyst approaching—the PDUFA...

Read more Investment Insights for Free


Explore Investment Categories

  • Cryptocurrency News
  • Investing Strategies
  • Investing Tools and Regulations
  • Investment Insights
  • Market News

Recent Market Alerts & Analysis

  • Alphabet (GOOG): Too Perfect to Fall… Too Expensive to Buy?
  • GE Aerospace: The Industrial Phoenix Wall Street Can’t Ignore — But Should You Buy at $312?
  • ADBE (Adobe): the creative software cash machine under pressure – major opportunity or cycle breakdown?
  • CVX (Chevron): the global energy pillar facing the cycle – solid yield or oil-driven value trap?
  • CSCO (Cisco Systems): the quiet networking giant the market is rediscovering – steady value or a re-rating in the making?


Address

300 Park Avenue, 12th Floor New York, NY 10022, United States

}

Business hours

Open 24 hours from Monday to Sunday

Legal Notice

  • *Terms and conditions of sale
  • Privacy policy
  • FollowFollow
  • FollowFollow
  • FollowFollow
  • FollowFollow
  • FollowFollow
  • FollowFollow
  • FollowFollow
  • FollowFollow
  • FollowFollow
  • FollowFollow
Copyright © 2026 Bullish Stock Alerts. All Rights Reserved.